Your browser doesn't support javascript.
loading
Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2)-Positive Breast Cancer.
Braman, Nathaniel; Prasanna, Prateek; Whitney, Jon; Singh, Salendra; Beig, Niha; Etesami, Maryam; Bates, David D B; Gallagher, Katherine; Bloch, B Nicolas; Vulchi, Manasa; Turk, Paulette; Bera, Kaustav; Abraham, Jame; Sikov, William M; Somlo, George; Harris, Lyndsay N; Gilmore, Hannah; Plecha, Donna; Varadan, Vinay; Madabhushi, Anant.
Afiliación
  • Braman N; Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio.
  • Prasanna P; Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio.
  • Whitney J; Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio.
  • Singh S; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio.
  • Beig N; Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio.
  • Etesami M; Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut.
  • Bates DDB; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Gallagher K; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Bloch BN; Department of Radiology, Boston Medical Center, Boston, Massachusetts.
  • Vulchi M; Department of Radiology, Boston University School of Medicine, Boston, Massachusetts.
  • Turk P; Department of Hematology and Medical Oncology, The Cleveland Clinic, Cleveland, Ohio.
  • Bera K; Department of Diagnostic Radiology, The Cleveland Clinic, Cleveland, Ohio.
  • Abraham J; Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio.
  • Sikov WM; Department of Hematology and Medical Oncology, The Cleveland Clinic, Cleveland, Ohio.
  • Somlo G; Program in Women's Oncology, Women and Infants Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island.
  • Harris LN; Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, California.
  • Gilmore H; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California.
  • Plecha D; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio.
  • Varadan V; National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Madabhushi A; Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio.
JAMA Netw Open ; 2(4): e192561, 2019 04 05.
Article en En | MEDLINE | ID: mdl-31002322
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Radiometría / Neoplasias de la Mama / Imagen por Resonancia Magnética / Receptor ErbB-2 Tipo de estudio: Evaluation_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: JAMA Netw Open Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Radiometría / Neoplasias de la Mama / Imagen por Resonancia Magnética / Receptor ErbB-2 Tipo de estudio: Evaluation_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: JAMA Netw Open Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos